Anti-NMDA Receptor Encephalitis With Visual Hallucinations and Cognitive Impairment
September 15th 2020In comparison to the classic presentation of schizophrenia, ANMDARE features a later age of onset, female predominance, visual hallucinations, relative lack of cognitive disorganization, and a lack of an extended prodromal period.
Read More
Key Concepts About Polypharmacy in Psychotic Disorders
August 3rd 2020Clinicians should keep in mind the risk-to-benefit ratio considerations before initiating polypharmacy, especially if they have patients with prescriptions inherited from several sources. Here: A summary of recommendations about the use of polypharmacy in psychotic disorders.
Read More
Rediscovering Disordered Selfhood in Schizophrenia
June 8th 2020Familiarity with self-disorders is an indispensable tool in diagnosing a patient suspected for developing schizophrenia. Such knowledge improves communication with the patient and may serve as a starting point for therapeutic intervention.
Read More
Riches Abound, So Where Are the Trials for Schizophrenia and Bipolar Disorder?
May 5th 2020Schizophrenia and bipolar disorder are among the most serious psychiatric disorders and play a disproportionate role among individuals who end up homeless, incarcerated, and who die by suicide. Why the lack of research?
Read More
Parkinson disease psychosis is associated with worsening quality of life, greater caregiver distress, higher rates of institutionalization, increased mortality, and greater health care costs. The authors explore medical, psychosocial, and psychological factors associated with PD psychosis.
Read More